Vestmark Advisory Solutions, Inc.
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1736982
Wakefield, MA
Position in RXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,601,507
+$369,660 QoQ
Shares Held
708,858
-2.5% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#45
of 343 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vestmark Advisory Solutions, Inc. holds $73,342,513 across 34 Biotechnology names. RXRX ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
242,266 | $13,213,187 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
532,817 | $9,015,263 | |
| 3 | TWST |
Twist Bioscience Corp
|
85,142 | $8,759,408 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
164,164 | $5,634,108 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,762 | $3,855,617 | |
| 6 | TECH |
BIO-TECHNE Corp
|
44,928 | $3,174,163 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
708,858 | $2,601,507 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,217 | $2,473,562 |
All Filings in RXRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,601,507 | 708,858 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,231,847 | 726,986 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,473,452 | 604,756 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,030,767 | 621,059 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,776,042 | 1,339,139 | Shares | Other | 2025-08-06 | |
| 2025-03-31 | $3,736,004 | 706,239 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,713,240 | 845,154 | Shares | Other | 2025-02-06 | |
| 2024-09-30 | $4,830,027 | 732,933 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,886,727 | 784,897 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,973,188 | 900,019 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,656,444 | 472,256 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||